Compass Pathways Plc Market Cap ($1.13 Billion)
Market Cap & Net Worth: Compass Pathways Plc (CMPS)
Compass Pathways Plc market cap. Compass Pathways Plc (NASDAQ:CMPS) has a market capitalization of $1.13 Billion ($1.13 Billion) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8095 globally and #2408 in its home market, demonstrating a -24.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Compass Pathways Plc's stock price $8.41 by its total outstanding shares 134923295 (134.92 Million). Also see Compass Pathways Plc cash conversion from operations for how efficiently the company converts equity into cash flow.
Compass Pathways Plc Market Cap History (2020–2026)
Compass Pathways Plc market cap history from 2020 to 2026. Data shows change from $6.43 Billion to $1.13 Billion (-18.30% CAGR). Check CMPS stock price for real-time trading data and today's change.
Index Memberships
Compass Pathways Plc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.04% | #233 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #889 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.83 Trillion | 0.06% | #135 of 263 |
Weight: Compass Pathways Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Compass Pathways Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Compass Pathways Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Compass Pathways Plc (CMPS) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CMPS by Market Capitalization
Companies near Compass Pathways Plc in the global market cap rankings as of November 3, 2026. Also see CMPS total asset value for a full breakdown of the balance sheet.
Key companies related to Compass Pathways Plc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #907 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #989 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1217 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $467.73 |
| #907 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €48.58 |
| #989 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1217 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $268.89 |
Market Capitalization of Compass Pathways Plc (2020–2026)
Market capitalization of Compass Pathways Plc from 2020 to today. Between 2020 and today, Compass Pathways Plc's market cap moved from $6.43 Billion to $ 1.13 Billion, with a yearly change of -18.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.13 Billion | +21.88% |
| 2025 | $930.97 Million | +82.54% |
| 2024 | $510.01 Million | -56.80% |
| 2023 | $1.18 Billion | +8.97% |
| 2022 | $1.08 Billion | -63.67% |
| 2021 | $2.98 Billion | -53.61% |
| 2020 | $6.43 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Compass Pathways Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.13 Billion USD |
| MoneyControl | $1.13 Billion USD |
| MarketWatch | $1.13 Billion USD |
| marketcap.company | $1.13 Billion USD |
| Reuters | $1.13 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Compass Pathways Plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly … Read more